/or its subsidiaries for not exceeding 225,000,000 units, which is subjected to Shareholders' approval; details of which are shown in Attachment 1. The Board also approved to authorize the Chairman or
. ………………………………………………………………………… The Company hereby informs of the details on the transactions as follows: 1. Transaction Date The representative on behalf of Wattanapat Samui Hospital project signed the Land Sale and Purchase
. The details are as follows: Name of the Company: Dolsiri Development Co., Ltd. Objective: To develop, rent out and manage real estate projects Registered Capital: 1,000,000 THB (One Million Baht Only
financial statements of the Company and its subsidiaries for the third quarter of 2019 which reviewed by the auditor of the Company. Details are as follows. 1. The Operating Results Analysis For the third
subsidiaries for the Second Quarter Ended June 30, 2017. The auditor of the Company with details has reviewed these as follows. 1. The Analysis of Operating Results For the quarter ended June 30, 2017 The
required to immediately prepare a report and disclose the information memorandum to the Stock Exchange. The information memorandum must set out the minimum details as required by Schedule 1 of the
capital increase is to expand the capacity of flexible packaging products, to repay the loans and used as working capital. Details are shown in Capital Increase Report Form (F 53-4) (Attachment 1). 4
subsidiaries for the Third Quarter Ended September 30, 2017. The auditor of the Company with details has reviewed these as follows. 1. The Analysis of Operating Results For the quarter ended September 30, 2017
Company hereby informs of the details on the transactions as follows: 1. Transaction Date Launching the new project of Wattanapat Samui Hospital will be started in February 2019 and will be completed in the